Biomarkers for Heart Failure Hospitalization Identified in Patients With AF
Investigators sought to identify biomarkers for determining risk for developing HF and death in patients with atrial fibrillation.
Investigators sought to identify biomarkers for determining risk for developing HF and death in patients with atrial fibrillation.
Investigators compared the long-term effects of febuxostat on arterial stiffness and atherosclerosis in patients with hyperuricemia and gout.
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
In this Q&A, Erica Johnson, MD, provides insight into the new oral antiviral medications that may soon be approved for the treatment of COVID-19.
Researchers conducted a study to assess whether an at-home neutralizing monoclonal antibody infusion program decreases the risk for hospitalization among patients with SARS-CoV-2 infection at increased risk for progression to severe disease.
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
How much do your patients know about the dangers of high potassium levels in the body? They may know that potassium is good for you, or that you need specific levels of it in the blood, but they may not know the effects of high potassium, or hyperkalemia. As their healthcare professional, how can you educate them on the dangers of hyperkalemia?